Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
42.05
-1.33 (-3.07%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Agios Pharmaceuticals Employees
Agios Pharmaceuticals had 386 employees as of December 31, 2023. The number of employees decreased by 7 or -1.78% compared to the previous year.
Employees
386
Change (1Y)
-7
Growth (1Y)
-1.78%
Revenue / Employee
$76,174
Profits / Employee
-$913,521
Market Cap
2.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 386 | -7 | -1.78% |
Dec 31, 2022 | 393 | 1 | 0.26% |
Dec 31, 2021 | 392 | -170 | -30.25% |
Dec 31, 2020 | 562 | 26 | 4.85% |
Dec 31, 2019 | 536 | 54 | 11.20% |
Dec 31, 2018 | 482 | 100 | 26.18% |
Dec 31, 2017 | 382 | 95 | 33.10% |
Dec 31, 2016 | 287 | 79 | 37.98% |
Dec 31, 2015 | 208 | 80 | 62.50% |
Dec 31, 2014 | 128 | 32 | 33.33% |
Dec 31, 2013 | 96 | 12 | 14.29% |
Dec 31, 2012 | 84 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
Integra LifeSciences Holdings | 3,946 |
Tandem Diabetes Care | 2,400 |
agilon health | 1,117 |
STAAR Surgical Company | 1,115 |
PTC Therapeutics | 995 |
Iovance Biotherapeutics | 557 |
Celldex Therapeutics | 160 |
AGIO News
- 4 weeks ago - Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study - Reuters
- 4 weeks ago - Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia - GlobeNewsWire
- 4 weeks ago - Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 - GlobeNewsWire
- 7 weeks ago - Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress - GlobeNewsWire
- 2 months ago - Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024 - GlobeNewsWire
- 2 months ago - Agios Reports Business Highlights and First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024 - GlobeNewsWire
- 4 months ago - Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024 - GlobeNewsWire